Commission Implementing Decision (EU) 2025/1792 of 10 September 2025 postponing the expiry date of the approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1792
11.9.2025

(1)
Ethyl butylacetylaminopropionate was approved as an active substance for use in biocidal products of product-type 19 by Commission Implementing Regulation (EU) No 406/2014(2)subject to the conditions set out in the Annex to that Regulation.

(2)
The approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 (‘the approval’) is to expire on 31 October 2025. On 25 April 2024, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the application’).

(3)
On 12 June 2024, the evaluating competent authority of Belgium informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the application was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4)
The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5)
Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6)
Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinion and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 April 2028.

(7)
After the postponement of the expiry date of the approval, ethyl butylacetylaminopropionate remains approved for use in biocidal products of product-type 19 subject to the conditions set out in the Annex to Implementing Regulation (EU) No 406/2014,

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,

After consulting the Standing Committee on Biocidal Products,

Whereas:

(1) Ethyl butylacetylaminopropionate was approved as an active substance for use in biocidal products of product-type 19 by Commission Implementing Regulation (EU) No 406/2014 (2) subject to the conditions set out in the Annex to that Regulation.

(2) The approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 (‘the approval’) is to expire on 31 October 2025. On 25 April 2024, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the application’).

(3) On 12 June 2024, the evaluating competent authority of Belgium informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the application was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6) Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinion and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 April 2028.

(7) After the postponement of the expiry date of the approval, ethyl butylacetylaminopropionate remains approved for use in biocidal products of product-type 19 subject to the conditions set out in the Annex to Implementing Regulation (EU) No 406/2014,

HAS ADOPTED THIS DECISION:
The expiry date of the approval of ethyl butylacetylaminopropionate for use in biocidal products of product-type 19 set out in the Annex to Implementing Regulation (EU) No 406/2014, is postponed to 30 April 2028.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Commission Implementing Decision (EU) 2025/1791 of 10 September 2025 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1791
11.9.2025

(1)
Imidacloprid was included in Annex I to Directive 98/8/EC of the European Parliament and of the Council(2)as an active substance for use in biocidal products of product-type 18. Pursuant to Article 86 of Regulation (EU) No 528/2012, it was therefore considered approved until 30 June 2023 under that Regulation subject to the conditions set out in Annex I to Directive 98/8/EC.

(2)
On 23 and 24 December 2021, two applications were submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of imidacloprid for use in biocidal products of product-type 18 (‘the applications’).

(3)
On 27 April 2022, the evaluating competent authority of Germany informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the applications was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4)
The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5)
Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency (‘the Agency’) is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6)
Commission Implementing Decision (EU) 2023/460(3)postponed the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 to 31 December 2025, in order to allow sufficient time for the examination of the applications.

(7)
On 26 February 2025, the evaluating competent authority informed the Commission that the evaluation is delayed due to the need for additional time to complete the assessment of endocrine-disrupting properties. The evaluating competent authority expects to submit the renewal assessment report to the Agency in the first half of 2026.

(8)
Consequently, for reasons beyond the control of the applicants, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to further postpone the expiry date of the approval for a period of time sufficient to enable the examination of the applications. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the Agency of its opinion and the time needed for the Commission to decide whether to renew the approval of imidacloprid for use in biocidal products of product-type 18, the expiry date should be postponed to 31 December 2027.

(9)
After the further postponement of the expiry date of the approval, imidacloprid remains approved for use in biocidal products of product-type 18 subject to the conditions set out in Annex I to Directive 98/8/EC,

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,

After consulting the Standing Committee on Biocidal Products,

Whereas:

(1) Imidacloprid was included in Annex I to Directive 98/8/EC of the European Parliament and of the Council (2) as an active substance for use in biocidal products of product-type 18. Pursuant to Article 86 of Regulation (EU) No 528/2012, it was therefore considered approved until 30 June 2023 under that Regulation subject to the conditions set out in Annex I to Directive 98/8/EC.

(2) On 23 and 24 December 2021, two applications were submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of imidacloprid for use in biocidal products of product-type 18 (‘the applications’).

(3) On 27 April 2022, the evaluating competent authority of Germany informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the applications was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency (‘the Agency’) is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6) Commission Implementing Decision (EU) 2023/460 (3) postponed the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 to 31 December 2025, in order to allow sufficient time for the examination of the applications.

(7) On 26 February 2025, the evaluating competent authority informed the Commission that the evaluation is delayed due to the need for additional time to complete the assessment of endocrine-disrupting properties. The evaluating competent authority expects to submit the renewal assessment report to the Agency in the first half of 2026.

(8) Consequently, for reasons beyond the control of the applicants, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to further postpone the expiry date of the approval for a period of time sufficient to enable the examination of the applications. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the Agency of its opinion and the time needed for the Commission to decide whether to renew the approval of imidacloprid for use in biocidal products of product-type 18, the expiry date should be postponed to 31 December 2027.

(9) After the further postponement of the expiry date of the approval, imidacloprid remains approved for use in biocidal products of product-type 18 subject to the conditions set out in Annex I to Directive 98/8/EC,

HAS ADOPTED THIS DECISION:
The expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 set out in Implementing Decision (EU) 2023/460 is postponed to 31 December 2027.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Council Decision (CFSP) 2025/1790 of 5 September 2025 amending Decision (CFSP) 2020/1999 concerning restrictive measures against serious human rights violations and abuses

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1790
5.9.2025

(1)
On 7 December 2020, the Council adopted Decision (CFSP) 2020/1999(1).

(2)
On 8 December 2020, by way of the Declaration by the High Representative of the Union for Foreign Affairs and Security Policy (the ‘High Representative’), on behalf of the European Union regarding the EU Global Human Rights Sanctions Regime, the Union and its Member States reaffirmed their strong commitment to the promotion and protection of human rights around the world. The EU Global Human Rights Sanctions Regime underscores the Union’s determination to enhance its role in addressing serious human rights violations and abuses worldwide. Achieving the effective enjoyment of human rights for every person is a strategic goal of the Union. Respect for human dignity, freedom, democracy, equality, the rule of law and human rights is a fundamental value of the Union and its common foreign and security policy.

(3)
In its conclusions of 19 December 2024, the European Council reiterated its resolute condemnation of Russia’s war of aggression against Ukraine, which constitutes a manifest violation of the Charter of the United Nations, and reaffirmed its continued support for Ukraine’s independence, sovereignty and territorial integrity within its internationally recognised borders. The Union does not recognise and continues to condemn the illegal annexation of Crimea and Sevastopol by the Russian Federation as a violation of international law.

(4)
Since the illegal annexation of Crimea and Sevastopol by the Russian Federation in 2014, the human rights situation in the Crimean peninsula has significantly deteriorated. Residents of the peninsula face systematic restrictions on their fundamental freedoms, and serious human rights violations occur in Crimean detention centres, including cruel, inhuman, and degrading treatment of detainees.

(5)
In that context, two persons should be included in the list of natural and legal persons, entities and bodies subject to restrictive measures set out in the Annex to Decision (CFSP) 2020/1999.

(6)
Decision (CFSP) 2020/1999 should therefore be amended accordingly,

Names (Transliteration into Latin script)
Names
Identifying information
Reasons for listing
Date of listing

‘134.
Vadim Viktorovich BULGAKOVa.k.a.Vadym Viktorovych BULHAKOV
Вадим Викторович БУЛГАКОВ(Russian spelling)
Position: Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”DOB: 30.1.1969POB: Simferopol, UkraineNationality: Ukrainian, RussianTax ID Ukraine (ДРФО): 2523214611Tax ID Russia (ИНН): 910218275068Gender: maleAddress: Simferopol, Autonomous Republic of Crimea, UkraineAssociated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Aleksei Nikolaevich Pikin, Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”
Since November 2014, Vadim Bulgakov is the Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”. He holds sole authority over the Directorate’s activities and, as such, bears personal responsibility for, among other things, the proper provision of medical services to detainees and prisoners in Crimea. In this capacity, he is accountable for the widespread and systematic denial of adequate medical care and treatment to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.Since his appointment as Head of the Directorate in 2014, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.Therefore, Vadim Bulgakov is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.
5.9.2025

135.
Aleksei Nikolaevich PIKINa.k.a.Alexey Nikolaevich PIKIN
Алексей Николаевич ПИКИН(Russian spelling)
Position: Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”DOB: 9.8.1975Nationality: RussianGender: maleAddress: Voronezh, Voronezh Region, RussiaAssociated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Vadim Viktorovich Bulgakov, Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”
Aleksei Pikin is the Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol” since May 2016. Within that structure, he holds responsibility for the management and coordination of the regional penal system in Crimea and Sevastopol, including staff conduct, inmate welfare, and the prevention of law violations within detention facilities. Given this mandate, he bears responsibility for any human rights violations committed against individuals sentenced to imprisonment in Crimea, including abuses by staff, unlawful disciplinary measures, or failure to prevent torture, mistreatment, or denial of basic rights within the penal system. He is accountable for widespread and systematic denial of adequate medical care and treatment provision to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.Since his appointment as Deputy Head in 2016, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred under his authority at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.Therefore, Aleksei Pikin is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.
5.9.2025’

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on European Union, and in particular Article 29 thereof,

Having regard to the proposal from the High Representative of the Union for Foreign Affairs and Security Policy,

Whereas:

(1) On 7 December 2020, the Council adopted Decision (CFSP) 2020/1999 (1).

(2) On 8 December 2020, by way of the Declaration by the High Representative of the Union for Foreign Affairs and Security Policy (the ‘High Representative’), on behalf of the European Union regarding the EU Global Human Rights Sanctions Regime, the Union and its Member States reaffirmed their strong commitment to the promotion and protection of human rights around the world. The EU Global Human Rights Sanctions Regime underscores the Union’s determination to enhance its role in addressing serious human rights violations and abuses worldwide. Achieving the effective enjoyment of human rights for every person is a strategic goal of the Union. Respect for human dignity, freedom, democracy, equality, the rule of law and human rights is a fundamental value of the Union and its common foreign and security policy.

(3) In its conclusions of 19 December 2024, the European Council reiterated its resolute condemnation of Russia’s war of aggression against Ukraine, which constitutes a manifest violation of the Charter of the United Nations, and reaffirmed its continued support for Ukraine’s independence, sovereignty and territorial integrity within its internationally recognised borders. The Union does not recognise and continues to condemn the illegal annexation of Crimea and Sevastopol by the Russian Federation as a violation of international law.

(4) Since the illegal annexation of Crimea and Sevastopol by the Russian Federation in 2014, the human rights situation in the Crimean peninsula has significantly deteriorated. Residents of the peninsula face systematic restrictions on their fundamental freedoms, and serious human rights violations occur in Crimean detention centres, including cruel, inhuman, and degrading treatment of detainees.

(5) In that context, two persons should be included in the list of natural and legal persons, entities and bodies subject to restrictive measures set out in the Annex to Decision (CFSP) 2020/1999.

(6) Decision (CFSP) 2020/1999 should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:
The Annex to Decision (CFSP) 2020/1999 is amended in accordance with the Annex to this Decision.
This Decision shall enter into force on the date of its publication in the Official Journal of the European Union.
In the Annex to Decision (CFSP) 2020/1999, the following entries are added to the list of natural and legal persons, entities and bodies under heading ‘A. Natural persons’:

Names (Transliteration into Latin script)

Names

Identifying information

Reasons for listing

Date of listing

‘134. Vadim Viktorovich BULGAKOV

a.k.a.

Vadym Viktorovych BULHAKOV

Вадим Викторович БУЛГАКОВ

(Russian spelling)

Position: Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”

DOB: 30.1.1969

POB: Simferopol, Ukraine

Nationality: Ukrainian, Russian

Tax ID Ukraine (ДРФО): 2523214611

Tax ID Russia (ИНН): 910218275068

Gender: male

Address: Simferopol, Autonomous Republic of Crimea, Ukraine

Associated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Aleksei Nikolaevich Pikin, Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”

Since November 2014, Vadim Bulgakov is the Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”. He holds sole authority over the Directorate’s activities and, as such, bears personal responsibility for, among other things, the proper provision of medical services to detainees and prisoners in Crimea. In this capacity, he is accountable for the widespread and systematic denial of adequate medical care and treatment to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.

Since his appointment as Head of the Directorate in 2014, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.

Therefore, Vadim Bulgakov is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.

5.9.2025 135. Aleksei Nikolaevich PIKIN

a.k.a.

Alexey Nikolaevich PIKIN

Алексей Николаевич ПИКИН

(Russian spelling)

Position: Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”

DOB: 9.8.1975

Nationality: Russian

Gender: male

Address: Voronezh, Voronezh Region, Russia

Associated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Vadim Viktorovich Bulgakov, Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”

Aleksei Pikin is the Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol” since May 2016. Within that structure, he holds responsibility for the management and coordination of the regional penal system in Crimea and Sevastopol, including staff conduct, inmate welfare, and the prevention of law violations within detention facilities. Given this mandate, he bears responsibility for any human rights violations committed against individuals sentenced to imprisonment in Crimea, including abuses by staff, unlawful disciplinary measures, or failure to prevent torture, mistreatment, or denial of basic rights within the penal system. He is accountable for widespread and systematic denial of adequate medical care and treatment provision to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.

Since his appointment as Deputy Head in 2016, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred under his authority at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.

Therefore, Aleksei Pikin is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.

5.9.2025’

Commission Implementing Decision (EU) 2025/1786 of 9 September 2025 on the publication of a list indicating certain CO2 emissions values per manufacturer as well as average specific CO2 emissions of all new heavy-duty vehicles registered in the Union pursuant to Regulation (EU) 2019/1242 of the European Parliament and of the Council for the reporting period of the year 2023 (notified under document C(2025) 5985)

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1786
11.9.2025

(1)
The average specific CO2emissions of a manufacturer should be determined on the basis of data reported by Member States and manufacturers pursuant to Regulation (EU) 2018/956 of the European Parliament and of the Council(2)for vehicles of that manufacturer.

(2)
The average specific CO2emissions of all new heavy-duty vehicles registered in the Union should be based on the data reported for vehicles from all manufacturers.

(3)
The zero- and low-emission factor for each manufacturer should be determined taking into account the zero- and low-emission heavy-duty vehicles reported.

(4)
The CO2emission reduction trajectory and the emission credits per manufacturer should be determined on the basis of the number of new heavy-duty vehicles excluding vocational vehicles reported. Those vehicles, which were certified as vocational vehicles, but not registered as such, were identified and the necessary corrections to the annual average specific CO2emissions of a manufacturer in accordance with Commission Implementing Regulation (EU) 2021/941(3)were applied to them.

(5)
The data presented in the Annex to this Decision is based on the data available to the Commission on 26 June 2025.

(6)
The Commission may have to update the data published herein, should it receive additional data which would affect the results of those calculations,

(1)
DAF TRUCKS N.V.P.O. Box 900655600 PT EindhovenThe Netherlands
DAF TRUCKS N.V.
P.O. Box 90065
5600 PT Eindhoven
The Netherlands

DAF TRUCKS N.V.

P.O. Box 90065

5600 PT Eindhoven

The Netherlands

DAF TRUCKS N.V.

P.O. Box 90065

5600 PT Eindhoven

The Netherlands

(2)
DAIMLER TRUCK AGFasanenweg 1070771 Leinfelden-EchterdingenGermany
DAIMLER TRUCK AG
Fasanenweg 10
70771 Leinfelden-Echterdingen
Germany

DAIMLER TRUCK AG

Fasanenweg 10

70771 Leinfelden-Echterdingen

Germany

DAIMLER TRUCK AG

Fasanenweg 10

70771 Leinfelden-Echterdingen

Germany

(3)
FORD OTOMOTIV SANAYI A.Ş.Akpınar Mahallesi Hasan Basri Caddesi No: 234885 Sancaktepe/İstanbulTürkiye
FORD OTOMOTIV SANAYI A.Ş.
Akpınar Mahallesi Hasan Basri Caddesi No: 2
34885 Sancaktepe/İstanbul
Türkiye

FORD OTOMOTIV SANAYI A.Ş.

Akpınar Mahallesi Hasan Basri Caddesi No: 2

34885 Sancaktepe/İstanbul

Türkiye

FORD OTOMOTIV SANAYI A.Ş.

Akpınar Mahallesi Hasan Basri Caddesi No: 2

34885 Sancaktepe/İstanbul

Türkiye

(4)
HYUNDAI HYDROGEN MOBILITY AGHagenholzstrasse 608004 ZürichSwitzerland
HYUNDAI HYDROGEN MOBILITY AG
Hagenholzstrasse 60
8004 Zürich
Switzerland

HYUNDAI HYDROGEN MOBILITY AG

Hagenholzstrasse 60

8004 Zürich

Switzerland

HYUNDAI HYDROGEN MOBILITY AG

Hagenholzstrasse 60

8004 Zürich

Switzerland

(5)
IVECO MAGIRUS AGNicolaus-Otto-Straße 2789079 UlmGermany
IVECO MAGIRUS AG
Nicolaus-Otto-Straße 27
89079 Ulm
Germany

IVECO MAGIRUS AG

Nicolaus-Otto-Straße 27

89079 Ulm

Germany

IVECO MAGIRUS AG

Nicolaus-Otto-Straße 27

89079 Ulm

Germany

(6)
IVECO S.P.A.Via Puglia 3510156 TorinoItaly
IVECO S.P.A.
Via Puglia 35
10156 Torino
Italy

IVECO S.P.A.

Via Puglia 35

10156 Torino

Italy

IVECO S.P.A.

Via Puglia 35

10156 Torino

Italy

(7)
MAN TRUCK & BUS SEDachauer Straße 66780995 MünchenGermany
MAN TRUCK & BUS SE
Dachauer Straße 667
80995 München
Germany

MAN TRUCK & BUS SE

Dachauer Straße 667

80995 München

Germany

MAN TRUCK & BUS SE

Dachauer Straße 667

80995 München

Germany

(8)
OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 534788 Çekmeköy/İstanbulTürkiye
OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.
Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5
34788 Çekmeköy/İstanbul
Türkiye

OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.

Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5

34788 Çekmeköy/İstanbul

Türkiye

OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.

Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5

34788 Çekmeköy/İstanbul

Türkiye

(9)
RENAULT TRUCK SAS99 Route de Lyon69800 Saint-PriestFrance
RENAULT TRUCK SAS
99 Route de Lyon
69800 Saint-Priest
France

RENAULT TRUCK SAS

99 Route de Lyon

69800 Saint-Priest

France

RENAULT TRUCK SAS

99 Route de Lyon

69800 Saint-Priest

France

(10)
SCANIA CV ABVagnmakarvägen 1151 87 SödertäljeSweden
SCANIA CV AB
Vagnmakarvägen 1
151 87 Södertälje
Sweden

SCANIA CV AB

Vagnmakarvägen 1

151 87 Södertälje

Sweden

SCANIA CV AB

Vagnmakarvägen 1

151 87 Södertälje

Sweden

(11)
VOLVO TRUCK CORPORATIONHerkulesgatan 75405 08 GöteborgSweden
VOLVO TRUCK CORPORATION
Herkulesgatan 75
405 08 Göteborg
Sweden

VOLVO TRUCK CORPORATION

Herkulesgatan 75

405 08 Göteborg

Sweden

VOLVO TRUCK CORPORATION

Herkulesgatan 75

405 08 Göteborg

Sweden

Manufacturer
Average specific CO2emissions, as referred to in Article 4 of Regulation (EU) 2019/1242, in g/tkm
Zero- and low emission factor, as referred to in Article 5(1) of Regulation (EU) 2019/1242
CO2emissions reduction trajectory, as referred to in Article 7(2) of Regulation (EU) 2019/1242, in g/tkm
Emission credits, as referred to in Article 7(1) of Regulation (EU) 2019/1242, in g/tkm

DAF TRUCKS N.V.
47,72
0,999
49,54
64 053

DAIMLER TRUCK AG
47,75
0,990
47,45
–

FORD OTOMOTIV SANAYI A.Ş.
52,55
1,000
49,12
–

HYUNDAI HYDROGEN MOBILITY AG
0,00
0,970
50,60
1 518

IVECO MAGIRUS AG
50,08
1,000
46,35
–

IVECO S.P.A.
47,91
0,983
45,11
–

MAN TRUCK & BUS SE
46,68
0,999
47,29
20 456

OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.
36,21
1,000
28,52
–

RENAULT TRUCK SAS
43,45
0,970
45,70
45 111

SCANIA CV AB
44,13
0,996
48,38
168 905

VOLVO TRUCK CORPORATION
44,47
0,970
48,64
165 470

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2019/1242 of the European Parliament and of the Council of 20 June 2019 setting CO2 emission performance standards for new heavy-duty vehicles and amending Regulations (EC) No 595/2009 and (EU) 2018/956 of the European Parliament and of the Council and Council Directive 96/53/EC (1), and in particular Article 11(1), first subparagraph, points (a), (b), (d) and (f) thereof,

Whereas:

(1) The average specific CO2 emissions of a manufacturer should be determined on the basis of data reported by Member States and manufacturers pursuant to Regulation (EU) 2018/956 of the European Parliament and of the Council (2) for vehicles of that manufacturer.

(2) The average specific CO2 emissions of all new heavy-duty vehicles registered in the Union should be based on the data reported for vehicles from all manufacturers.

(3) The zero- and low-emission factor for each manufacturer should be determined taking into account the zero- and low-emission heavy-duty vehicles reported.

(4) The CO2 emission reduction trajectory and the emission credits per manufacturer should be determined on the basis of the number of new heavy-duty vehicles excluding vocational vehicles reported. Those vehicles, which were certified as vocational vehicles, but not registered as such, were identified and the necessary corrections to the annual average specific CO2 emissions of a manufacturer in accordance with Commission Implementing Regulation (EU) 2021/941 (3) were applied to them.

(5) The data presented in the Annex to this Decision is based on the data available to the Commission on 26 June 2025.

(6) The Commission may have to update the data published herein, should it receive additional data which would affect the results of those calculations,

HAS ADOPTED THIS DECISION:
Average specific CO2 emissions per manufacturerThe average specific CO2 emissions per manufacturer, as referred to in Article 4 of Regulation (EU) 2019/1242, in the reporting period of the year 2023, are indicated in the second column of the table of the Annex to this Decision.
Zero- and low-emission factor per manufacturerThe zero- and low-emission factor per manufacturer, as referred to in Article 5(1) of Regulation (EU) 2019/1242, in the reporting period of the year 2023, is indicated in the third column of the table of the Annex to this Decision.
CO2 emissions reduction trajectory and emissions credits per manufacturerThe CO2 emissions reduction trajectory and the emission credits per manufacturer, as referred to in Article 7 of Regulation (EU) 2019/1242, in the reporting period of the year 2023, are indicated in the fourth and fifth columns, respectively, of the table of the Annex to this Decision.
Average specific CO2 emissions of all new heavy-duty vehiclesThe average specific CO2 emissions of all new heavy-duty vehicles registered in the Union in the reporting period of the year 2023, as calculated by applying the formula of Annex I, point 2.7, to Regulation (EU) 2019/1242 taking into account the new heavy-duty vehicles of all manufacturers, is 46,7 g/tkm.
AddresseesThis Decision is addressed to the following manufacturers:
(1) DAF TRUCKS N.V.

P.O. Box 90065

5600 PT Eindhoven

The Netherlands

(2) DAIMLER TRUCK AG

Fasanenweg 10

70771 Leinfelden-Echterdingen

Germany

(3) FORD OTOMOTIV SANAYI A.Ş.

Akpınar Mahallesi Hasan Basri Caddesi No: 2

34885 Sancaktepe/İstanbul

Türkiye

(4) HYUNDAI HYDROGEN MOBILITY AG

Hagenholzstrasse 60

8004 Zürich

Switzerland

(5) IVECO MAGIRUS AG

Nicolaus-Otto-Straße 27

89079 Ulm

Germany

(6) IVECO S.P.A.

Via Puglia 35

10156 Torino

Italy

(7) MAN TRUCK & BUS SE

Dachauer Straße 667

80995 München

Germany

(8) OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.

Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5

34788 Çekmeköy/İstanbul

Türkiye

(9) RENAULT TRUCK SAS

99 Route de Lyon

69800 Saint-Priest

France

(10) SCANIA CV AB

Vagnmakarvägen 1

151 87 Södertälje

Sweden

(11) VOLVO TRUCK CORPORATION

Herkulesgatan 75

405 08 Göteborg

Sweden
All entries refer to the reporting period of the year 2023.
Manufacturer

Average specific CO2 emissions, as referred to in Article 4 of Regulation (EU) 2019/1242, in g/tkm

Zero- and low emission factor, as referred to in Article 5(1) of Regulation (EU) 2019/1242

CO2 emissions reduction trajectory, as referred to in Article 7(2) of Regulation (EU) 2019/1242, in g/tkm

Emission credits, as referred to in Article 7(1) of Regulation (EU) 2019/1242, in g/tkm

DAF TRUCKS N.V.

47,72 

0,999 

49,54 

64 053 

DAIMLER TRUCK AG

47,75 

0,990 

47,45 

–

FORD OTOMOTIV SANAYI A.Ş.

52,55 

1,000 

49,12 

–

HYUNDAI HYDROGEN MOBILITY AG

0,00 

0,970 

50,60 

1 518 

IVECO MAGIRUS AG

50,08 

1,000 

46,35 

–

IVECO S.P.A.

47,91 

0,983 

45,11 

–

MAN TRUCK & BUS SE

46,68 

0,999 

47,29 

20 456 

OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.

36,21 

1,000 

28,52 

–

RENAULT TRUCK SAS

43,45 

0,970 

45,70 

45 111 

SCANIA CV AB

44,13 

0,996 

48,38 

168 905 

VOLVO TRUCK CORPORATION

44,47 

0,970 

48,64 

165 470

Commission Implementing Decision (EU) 2025/1785 of 9 September 2025 amending Implementing Decision (EU) 2023/740 as regards the harmonised standards for certain ride-on toys (wave rollers) drafted in support of Directive 2009/48/EC of the European Parliament and of the Council

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1785
10.9.2025

(1)
In accordance with Article 13 of Directive 2009/48/EC, toys which are in conformity with harmonised standards or parts thereof, the references of which have been published in theOfficial Journal of the European Union, are presumed to be in conformity with the requirements covered by those standards or parts thereof set out in Article 10 of Directive 2009/48/EC and Annex II to that Directive.

(2)
On 4 April 2023, the Commission adopted Implementing Decision (EU) 2023/740(2), listing harmonised standards for toys. The list included standard EN 71-1:2014+A1:2018 Safety of toys – Part 1: Mechanical and physical properties.

(3)
In January 2024, Germany lodged a formal objection in respect of standard EN 71-1:2014+A1:2018 as regards certain ride-on toys, namely wave rollers. A wave-roller is a ride-on toy where the child is seated, the steering and propulsion of which are controlled with the feet and which have wheels within reach during use.

(4)
The ground of the formal objection was based on the alleged failure of the referenced harmonised standard to address the essential safety requirements of Directive 2009/48/EC as regards wave rollers.

(5)
According to the objection, that failure consists in the absence of requirements to ensure that crushing, shearing, jamming or trapping accidents are prevented when the child is driving a wave roller, where the wheel is close to the seat and is accessible while the toy is in use, especially considering that the child’s hands are free when using the wave roller and that the child is in a low sitting position. Fingers can be crushed, shorn, lacerated or torn off or they can be pulled into the gap between the wheel fork and the wheel by the directed force of the wheel.

(6)
Germany claimed that the risks presented by the wave rollers are not fully covered by EN 71-1 due to their mechanism and way of functioning and their means of propulsion, and the resulting risks during play. Although harmonised standard EN 71-1:2014+A1:2018 covers some risks on a case-by-case basis, not all the requisite crushing, shearing, jamming or trapping points are addressed: the requirements for ride-on toys in that standard are partly product-specific (for example, for toy bikes, toy scooters) or relate to certain toy components and definitions (for example, driving mechanisms, folding and sliding mechanisms). However, generic, hazard-based requirements for ride-on toys concerning crushing and shearing points and catching and trapping points, particularly for fingers and hands, are not covered by that standard. In particular, the definition of ‘driving mechanism’ in clause 3.19 of that standard does not include wave rollers and that standard does not fully cover the risk of crushing the hand or finger and the risk of shearing the finger. Germany thus concluded that, in the absence of such requirements, it cannot be ensured that wave rollers, although in conformity with harmonised standard EN 71-1:2014+A1:2018, meet all the essential safety requirements provided for in Directive 2009/48/EC.

(7)
On 28 February 2024, the Commission published the formal objection raised by Germany on the notification system(3)established pursuant to Article 12 of Regulation (EU) No 1025/2012 of the European Parliament and of the Council(4).

(8)
Technical Committee 52 of the European Committee for Standardisation (CEN) (‘CEN/TC 52’) reacted to the formal objection lodged by Germany by requesting more details regarding the accident, in particular concerning the specific risk and the model toy involved in the accident. CEN/TC 52 also inquired whether the rod depicted in the formal objection was a 5 mm or 12 mm diameter rod, arguing that the toy involved in the accident was not in compliance with the existing (published) standard, namely its clause 4.15.1.6 c) – which is the general requirement for finger entrapment for ride-on toys. CEN/TC 52’s assessment was based on the fact that one of the photos presented in the formal objection showed the entry of the smaller test rod into some gaps between the wheel and the frame, and it looked as if those same gaps would not accept the breadth of the probes or rods as specified in the respective test method of the existing standard, thus representing a non-compliance. According to that assessment, compliance with the existing standard may have prevented the injury or at least reduced its severity. CEN/TC 52, however, also drew the attention to the fact that work was already being carried out in its relevant working group to address the shortcomings identified by the German authorities in the formal objection, by revising the standards in question: the draft revised version provides, in clause 4.15, for new requirements for ride-on toys covering the risks of crushing and shearing of the finger.

(9)
Germany replied to CEN/TC 52’s comments by stating that some risks, notably shearing of a finger, entrapment and crushing of the hand by the pull in force of the wheel, crushing of finger or hand from turning of the handlebar were not addressed in the current (published) standard. According to Germany, revising clause 4.15 of harmonized standard EN 71-1:2014+A1:2018 by including new risk areas shows that the current version of the standard does not adequately cover all risks for this special type of ride-on toys at the moment and, therefore, that the standard does not address all the essential safety requirements that it aims to cover. Germany also pointed out that the formal objection was not raised only because of this one particular toy and accident, as there were various other similar products on the market with similar problems and risks areas that were not covered by the existing standard.

(10)
The formal objection was discussed in the Committee established by Article 22 of Regulation (EU) No 1025/2012 on 18 April 2024.

(11)
Having examined harmonised standard EN 71-1:2014+A1:2018 together with the representatives of Member States and stakeholders in the Expert Group on Toy Safety and the representatives of the Committee established by Article 22 of Regulation (EU) No 1025/2012, the Commission agrees with the analysis made in the objection, and concludes that the clauses of those harmonised standards that aim to cover the essential safety requirements set out in Article 10 of Directive 2009/48/EC and Annex II to that Directive do not adequately address the related risks, in particular the risk of crushing and shearing of the finger and of the hand, for this specific type of ride-on toy. Standard EN 71-1:2014+A1:2018 does not include specific requirements to ensure that children can play safely when using wave rollers, since it does not provide them with adequate protection against the risk of crushing and shearing of the fingers and of the hand. Consequently, the Commission considers that wave rollers designed and manufactured according to clauses 3.19 (definition of ‘driving mechanism’) and 4.15.1 of that standard can cause similar accidents and incidents involving children.

(12)
Nevertheless, the Commission considers that the other clauses of the relevant harmonised standard, which are not the object of the formal objection, remain valid to confer presumption of conformity with the essential safety requirements of Directive 2009/48/EC they aim to cover.

(13)
In view of the above, the references of the harmonised standard EN 71-1:2014+A1:2018, published by Implementing Decision (EU) 2023/740, should be published with a restriction in theOfficial Journal of the European Union. The restriction should exclude the specific clauses of those standards that aim to cover the requirement set out in Part I, point 3, of Annex II to Directive 2009/48/EC, namely the requirement that toys are to be designed and manufactured in such a way as not to present any risk or only the minimum risk inherent to their use which could be caused by the movement of their parts. Implementing Decision (EU) 2023/740 should therefore be amended accordingly.

(14)
Compliance with a harmonised standard confers a presumption of conformity with the corresponding essential requirements set out in Union harmonisation legislation from the date of publication of the reference of such standard in theOfficial Journal of the European Union. This Decision should therefore enter into force on the date of its publication,

‘1.
EN 71-1:2014+A1:2018Safety of toys – Part 1: Mechanical and physical propertiesRestriction: As regards clauses 3.19 (definition of ‘driving mechanism’) and 4.15.1 for wave rollers (a ride-on toy where the child is seated, the steering and propulsion of which are controlled with the feet, and which have wheels within reach during use), harmonised standard EN 71-1:2014+A1:2018 does not confer a presumption of conformity with the essential safety requirements set out in Article 10(2) of Directive 2009/48/EC and Part I, point 3, of Annex II to that Directive.’.

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Directive 2009/48/EC of the European Parliament and of the Council of 18 June 2009 on the safety of toys (1), and in particular Article 14(2) thereof,

Whereas:

(1) In accordance with Article 13 of Directive 2009/48/EC, toys which are in conformity with harmonised standards or parts thereof, the references of which have been published in the Official Journal of the European Union, are presumed to be in conformity with the requirements covered by those standards or parts thereof set out in Article 10 of Directive 2009/48/EC and Annex II to that Directive.

(2) On 4 April 2023, the Commission adopted Implementing Decision (EU) 2023/740 (2), listing harmonised standards for toys. The list included standard EN 71-1:2014+A1:2018 Safety of toys – Part 1: Mechanical and physical properties.

(3) In January 2024, Germany lodged a formal objection in respect of standard EN 71-1:2014+A1:2018 as regards certain ride-on toys, namely wave rollers. A wave-roller is a ride-on toy where the child is seated, the steering and propulsion of which are controlled with the feet and which have wheels within reach during use.

(4) The ground of the formal objection was based on the alleged failure of the referenced harmonised standard to address the essential safety requirements of Directive 2009/48/EC as regards wave rollers.

(5) According to the objection, that failure consists in the absence of requirements to ensure that crushing, shearing, jamming or trapping accidents are prevented when the child is driving a wave roller, where the wheel is close to the seat and is accessible while the toy is in use, especially considering that the child’s hands are free when using the wave roller and that the child is in a low sitting position. Fingers can be crushed, shorn, lacerated or torn off or they can be pulled into the gap between the wheel fork and the wheel by the directed force of the wheel.

(6) Germany claimed that the risks presented by the wave rollers are not fully covered by EN 71-1 due to their mechanism and way of functioning and their means of propulsion, and the resulting risks during play. Although harmonised standard EN 71-1:2014+A1:2018 covers some risks on a case-by-case basis, not all the requisite crushing, shearing, jamming or trapping points are addressed: the requirements for ride-on toys in that standard are partly product-specific (for example, for toy bikes, toy scooters) or relate to certain toy components and definitions (for example, driving mechanisms, folding and sliding mechanisms). However, generic, hazard-based requirements for ride-on toys concerning crushing and shearing points and catching and trapping points, particularly for fingers and hands, are not covered by that standard. In particular, the definition of ‘driving mechanism’ in clause 3.19 of that standard does not include wave rollers and that standard does not fully cover the risk of crushing the hand or finger and the risk of shearing the finger. Germany thus concluded that, in the absence of such requirements, it cannot be ensured that wave rollers, although in conformity with harmonised standard EN 71-1:2014+A1:2018, meet all the essential safety requirements provided for in Directive 2009/48/EC.

(7) On 28 February 2024, the Commission published the formal objection raised by Germany on the notification system (3) established pursuant to Article 12 of Regulation (EU) No 1025/2012 of the European Parliament and of the Council (4).

(8) Technical Committee 52 of the European Committee for Standardisation (CEN) (‘CEN/TC 52’) reacted to the formal objection lodged by Germany by requesting more details regarding the accident, in particular concerning the specific risk and the model toy involved in the accident. CEN/TC 52 also inquired whether the rod depicted in the formal objection was a 5 mm or 12 mm diameter rod, arguing that the toy involved in the accident was not in compliance with the existing (published) standard, namely its clause 4.15.1.6 c) – which is the general requirement for finger entrapment for ride-on toys. CEN/TC 52’s assessment was based on the fact that one of the photos presented in the formal objection showed the entry of the smaller test rod into some gaps between the wheel and the frame, and it looked as if those same gaps would not accept the breadth of the probes or rods as specified in the respective test method of the existing standard, thus representing a non-compliance. According to that assessment, compliance with the existing standard may have prevented the injury or at least reduced its severity. CEN/TC 52, however, also drew the attention to the fact that work was already being carried out in its relevant working group to address the shortcomings identified by the German authorities in the formal objection, by revising the standards in question: the draft revised version provides, in clause 4.15, for new requirements for ride-on toys covering the risks of crushing and shearing of the finger.

(9) Germany replied to CEN/TC 52’s comments by stating that some risks, notably shearing of a finger, entrapment and crushing of the hand by the pull in force of the wheel, crushing of finger or hand from turning of the handlebar were not addressed in the current (published) standard. According to Germany, revising clause 4.15 of harmonized standard EN 71-1:2014+A1:2018 by including new risk areas shows that the current version of the standard does not adequately cover all risks for this special type of ride-on toys at the moment and, therefore, that the standard does not address all the essential safety requirements that it aims to cover. Germany also pointed out that the formal objection was not raised only because of this one particular toy and accident, as there were various other similar products on the market with similar problems and risks areas that were not covered by the existing standard.

(10) The formal objection was discussed in the Committee established by Article 22 of Regulation (EU) No 1025/2012 on 18 April 2024.

(11) Having examined harmonised standard EN 71-1:2014+A1:2018 together with the representatives of Member States and stakeholders in the Expert Group on Toy Safety and the representatives of the Committee established by Article 22 of Regulation (EU) No 1025/2012, the Commission agrees with the analysis made in the objection, and concludes that the clauses of those harmonised standards that aim to cover the essential safety requirements set out in Article 10 of Directive 2009/48/EC and Annex II to that Directive do not adequately address the related risks, in particular the risk of crushing and shearing of the finger and of the hand, for this specific type of ride-on toy. Standard EN 71-1:2014+A1:2018 does not include specific requirements to ensure that children can play safely when using wave rollers, since it does not provide them with adequate protection against the risk of crushing and shearing of the fingers and of the hand. Consequently, the Commission considers that wave rollers designed and manufactured according to clauses 3.19 (definition of ‘driving mechanism’) and 4.15.1 of that standard can cause similar accidents and incidents involving children.

(12) Nevertheless, the Commission considers that the other clauses of the relevant harmonised standard, which are not the object of the formal objection, remain valid to confer presumption of conformity with the essential safety requirements of Directive 2009/48/EC they aim to cover.

(13) In view of the above, the references of the harmonised standard EN 71-1:2014+A1:2018, published by Implementing Decision (EU) 2023/740, should be published with a restriction in the Official Journal of the European Union. The restriction should exclude the specific clauses of those standards that aim to cover the requirement set out in Part I, point 3, of Annex II to Directive 2009/48/EC, namely the requirement that toys are to be designed and manufactured in such a way as not to present any risk or only the minimum risk inherent to their use which could be caused by the movement of their parts. Implementing Decision (EU) 2023/740 should therefore be amended accordingly.

(14) Compliance with a harmonised standard confers a presumption of conformity with the corresponding essential requirements set out in Union harmonisation legislation from the date of publication of the reference of such standard in the Official Journal of the European Union. This Decision should therefore enter into force on the date of its publication,

HAS ADOPTED THIS DECISION:
The Annex to Implementing Decision (EU) 2023/740 is amended in accordance with the Annex to this Decision.
This Decision shall enter into force on the day of its publication in the Official Journal of the European Union.
In the Annex to Implementing Decision (EU) 2023/740, row 1 is replaced by the following:
‘1. EN 71-1:2014+A1:2018

Safety of toys – Part 1: Mechanical and physical properties

Restriction: As regards clauses 3.19 (definition of ‘driving mechanism’) and 4.15.1 for wave rollers (a ride-on toy where the child is seated, the steering and propulsion of which are controlled with the feet, and which have wheels within reach during use), harmonised standard EN 71-1:2014+A1:2018 does not confer a presumption of conformity with the essential safety requirements set out in Article 10(2) of Directive 2009/48/EC and Part I, point 3, of Annex II to that Directive.’.

Commission Decision (EU) 2025/1780 of 9 September 2025 adopting the Network Performance Plan for the fourth reference period of the Single European Sky performance scheme (2025–2029) (notified under document C(2025) 5968)

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1780
10.9.2025

(1)
Pursuant to Article 10(5) of Implementing Regulation (EU) 2019/317, the Network Manager is to draw up the Network Performance Plan, which is subject to the assessment by the Commission in accordance with Article 19(2) of that Implementing Regulation.

(2)
On 6 December 2024, the Network Manager submitted to the Commission a draft Network Performance Plan for the fourth reference period (‘RP4’).

(3)
Pursuant to Article 19(2) of Implementing Regulation (EU) 2019/317, the Commission, assisted by the Performance Review Body, has assessed the draft Network Performance Plan against the criteria laid down in Annex V to that Implementing Regulation. That assessment has shown that the draft Network Performance Plan meets those criteria.

(4)
It is therefore appropriate for the Commission to adopt the draft Network Performance Plan for RP4(4)as drawn up by the Network Manager and submitted to the Commission on 6 December 2024,

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 549/2004 of the European Parliament and of the Council of 10 March 2004 laying down the framework for the creation of the single European sky (the framework Regulation) (1), and in particular Article 11(1) thereof,

Having regard to Regulation (EU) 2024/2803 of the European Parliament and of the Council of 23 October 2024 on the implementation of the Single European Sky (2), and in particular Article 58(3) thereof,

Having regard to Commission Implementing Regulation (EU) 2019/317 of 11 February 2019 laying down a performance and charging scheme in the Single European Sky and repealing Implementing Regulations (EU) No 390/2013 and (EU) No 391/2013 (3), and in particular Article 19(3) thereof,

Whereas:

(1) Pursuant to Article 10(5) of Implementing Regulation (EU) 2019/317, the Network Manager is to draw up the Network Performance Plan, which is subject to the assessment by the Commission in accordance with Article 19(2) of that Implementing Regulation.

(2) On 6 December 2024, the Network Manager submitted to the Commission a draft Network Performance Plan for the fourth reference period (‘RP4’).

(3) Pursuant to Article 19(2) of Implementing Regulation (EU) 2019/317, the Commission, assisted by the Performance Review Body, has assessed the draft Network Performance Plan against the criteria laid down in Annex V to that Implementing Regulation. That assessment has shown that the draft Network Performance Plan meets those criteria.

(4) It is therefore appropriate for the Commission to adopt the draft Network Performance Plan for RP4 (4) as drawn up by the Network Manager and submitted to the Commission on 6 December 2024,

HAS ADOPTED THIS DECISION:
The Network Performance Plan for the fourth reference period of the Single European Sky performance scheme (2025–2029), submitted by the Network Manager on 6 December 2024, is adopted.
This Decision is addressed to Eurocontrol as Network Manager.

Commission Implementing Decision (EU) 2025/1779 of 11 September 2025 postponing the expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1779
12.9.2025

(1)
Azoxystrobin was approved as an active substance for use in biocidal products of product-types 7, 9 and 10 by Commission Implementing Regulation (EU) 2018/614(2)subject to the conditions set out in the Annex to that Regulation.

(2)
The approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 (‘the approval’) is to expire on 31 October 2025. On 25 April 2024, applications were submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the applications’).

(3)
On 28 June 2024, the evaluating competent authority of Denmark informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the applications was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4)
The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5)
Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6)
Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the applications. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinions and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 April 2028.

(7)
After the postponement of the expiry date of the approval, azoxystrobin remains approved for use in biocidal products of product-types 7, 9 and 10 subject to the conditions set out in the Annex to Implementing Regulation (EU) 2018/614,

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,

After consulting the Standing Committee on Biocidal Products,

Whereas:

(1) Azoxystrobin was approved as an active substance for use in biocidal products of product-types 7, 9 and 10 by Commission Implementing Regulation (EU) 2018/614 (2) subject to the conditions set out in the Annex to that Regulation.

(2) The approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 (‘the approval’) is to expire on 31 October 2025. On 25 April 2024, applications were submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the applications’).

(3) On 28 June 2024, the evaluating competent authority of Denmark informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the applications was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6) Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the applications. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinions and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 April 2028.

(7) After the postponement of the expiry date of the approval, azoxystrobin remains approved for use in biocidal products of product-types 7, 9 and 10 subject to the conditions set out in the Annex to Implementing Regulation (EU) 2018/614,

HAS ADOPTED THIS DECISION:
The expiry date of the approval of azoxystrobin for use in biocidal products of product-types 7, 9 and 10 set out in the Annex to Implementing Regulation (EU) 2018/614, is postponed to 30 April 2028.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Commission Implementing Decision (EU) 2025/1778 of 11 September 2025 postponing the expiry date of the approval of copper pyrithione for use in biocidal products of product-type 21 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1778
12.9.2025

(1)
Copper pyrithione was approved as an active substance for use in biocidal products of product-type 21 by Commission Implementing Regulation (EU) 2015/984(2)subject to the conditions set out in the Annex to that Regulation.

(2)
The approval of copper pyrithione for use in biocidal products of product-type 21 (‘the approval’) is to expire on 31 December 2025. On 27 June 2024, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the application’).

(3)
On 14 August 2024, the evaluating competent authority of Sweden informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the application was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4)
The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5)
Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6)
Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinion and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 June 2028.

(7)
After the postponement of the expiry date of the approval, copper pyrithione remains approved for use in biocidal products of product-type 21 subject to the conditions set out in the Annex to Implementing Regulation (EU) 2015/984,

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 14(5) thereof,

After consulting the Standing Committee on Biocidal Products,

Whereas:

(1) Copper pyrithione was approved as an active substance for use in biocidal products of product-type 21 by Commission Implementing Regulation (EU) 2015/984 (2) subject to the conditions set out in the Annex to that Regulation.

(2) The approval of copper pyrithione for use in biocidal products of product-type 21 (‘the approval’) is to expire on 31 December 2025. On 27 June 2024, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval (‘the application’).

(3) On 14 August 2024, the evaluating competent authority of Sweden informed the Commission that it had decided, pursuant to Article 14(1) of Regulation (EU) No 528/2012, that a full evaluation of the application was necessary. Pursuant to Article 8(1) of that Regulation, the evaluating competent authority is to perform a full evaluation of the application within 365 days of its validation.

(4) The evaluating competent authority may, as appropriate, require the applicant to provide sufficient data to carry out the evaluation, in accordance with Article 8(2) of Regulation (EU) No 528/2012. In that event, the 365-day period is suspended for a period that may not exceed 180 days in total unless a longer suspension is justified by the nature of the data requested or by exceptional circumstances.

(5) Within 270 days of receipt of a recommendation from the evaluating competent authority, the European Chemicals Agency is to prepare and submit to the Commission an opinion on renewal of the approval of the active substance in accordance with Article 14(3) of Regulation (EU) No 528/2012.

(6) Consequently, for reasons beyond the control of the applicant, the approval is likely to expire before a decision has been taken on its renewal. It is therefore appropriate to postpone the expiry date of the approval for a period of time sufficient to enable the examination of the application. Taking into account the time-limits for evaluation by the evaluating competent authority, for preparation and submission by the European Chemicals Agency of its opinion and the time needed for the Commission to decide whether to renew the approval, the expiry date should be postponed to 30 June 2028.

(7) After the postponement of the expiry date of the approval, copper pyrithione remains approved for use in biocidal products of product-type 21 subject to the conditions set out in the Annex to Implementing Regulation (EU) 2015/984,

HAS ADOPTED THIS DECISION:
The expiry date of the approval of copper pyrithione for use in biocidal products of product-type 21 set out in the Annex to Implementing Regulation (EU) 2015/984, is postponed to 30 June 2028.
This Decision shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

Commission Implementing Decision (EU) 2025/1777 of 2 September 2025 amending the Annex to Implementing Decision (EU) 2023/2447 concerning emergency measures in relation to outbreaks of highly pathogenic avian influenza in certain Member States (notified under document C(2025) 6024)

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1777
5.9.2025

(1)
Highly pathogenic avian influenza (HPAI) is an infectious viral disease in birds and can have a severe impact on the profitability of poultry farming causing disturbance to trade within the Union and exports to third countries. HPAI viruses can infect migratory birds, which can then spread these viruses over long distances during their autumn and spring migrations. Therefore, the presence of HPAI viruses in wild birds poses a continuous threat for the direct and indirect introduction of these viruses into holdings where poultry or captive birds are kept. In the event of an outbreak of HPAI, there is a risk that the disease agent may spread to other holdings where poultry or captive birds are kept.

(2)
Regulation (EU) 2016/429 establishes the legislative framework for the prevention and control of diseases that are transmissible to animals or humans. HPAI falls within the definition of a listed disease in that Regulation, and it is subject to the disease prevention and control rules laid down therein. In addition, Commission Delegated Regulation (EU) 2020/687(2)supplements Regulation (EU) 2016/429 as regards the rules for the prevention and control of certain listed diseases, including disease control measures for HPAI.

(3)
On 24 October 2023, the Commission adopted Commission Implementing Decision (EU) 2023/2447(3)on the basis of Regulation (EU) 2016/429, and it lays down emergency measures at Union level in relation to outbreaks of HPAI.

(4)
In particular, Implementing Decision (EU) 2023/2447 provides that the protection, surveillance and further restricted zones, to be established by the concerned Member States following outbreaks of HPAI, in accordance with Delegated Regulation (EU) 2020/687, must comprise at least the areas listed as protection, surveillance and further restricted zones in the Annex to that Implementing Decision. It also provides that the measures to be applied in those zones, in accordance with that Delegated Regulation, must be maintained until at least the dates set out in that Annex.

(5)
The Annex to Implementing Decision (EU) 2023/2447 was recently amended by Commission Implementing Decision (EU) 2025/1750(4)following new outbreaks of HPAI in Spain and Portugal in establishments where captive birds were kept, which needed to be reflected in that Annex.

(6)
Since the date of adoption of Implementing Decision (EU) 2025/1750, Bulgaria notified the Commission of three outbreaks of HPAI in establishments where poultry were kept, located in the Plovdiv region.

(7)
Following those outbreaks, Bulgaria has taken the disease control measures required in accordance with Delegated Regulation (EU) 2020/687, including the establishment of protection and surveillance zones around the outbreaks.

(8)
The Commission has examined the disease control measures taken by Bulgaria and it is satisfied that the boundaries of the protection and surveillances zones established by that Member State are at a sufficient distance from the establishment where the outbreaks of HPAI have been confirmed.

(9)
In the Annex to Implementing Decision (EU) 2023/2447, there are currently no areas listed as protection and surveillance zones for Bulgaria.

(10)
In order to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade being imposed by third countries, it is necessary to rapidly lay down at Union level, in collaboration with Bulgaria, the protection and surveillance zones established by that Member State, in accordance with Delegated Regulation (EU) 2020/687.

(11)
Therefore, protection and surveillance zones for Bulgaria should be listed in the Annex to Implementing Decision (EU) 2023/2447.

(12)
Accordingly, the Annex to Implementing Decision (EU) 2023/2447 should be amended to update regionalisation at Union level in order to take account of the protection and surveillance zones established by Bulgaria, in accordance with Delegated Regulation (EU) 2020/687, as well as to set out the duration of the measures applicable therein.

(13)
Implementing Decision (EU) 2023/2447 should therefore be amended accordingly.

(14)
Given the urgency of the epidemiological situation in the Union as regards the spread of HPAI, it is important that the amendments to be made to Implementing Decision (EU) 2023/2447 by this Decision take effect as soon as possible.

(15)
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

ADIS reference number of the outbreak
Area comprising:
Date until applicable in accordance with Article 39 of Delegated Regulation (EU) 2020/687

Plovdiv region

BG-HPAI(P)-2025-00008BG-HPAI(P)-2025-00009BG-HPAI(P)-2025-000010
The following villages in Rakovski municipality:—Rakovski—Momino seloThe following villages in Kaloyanovo municipality:—Glavatar
—
Rakovski
—
Momino selo
—
Glavatar
21.9.2025

—
Rakovski

—
Momino selo

—
Glavatar

—
Rakovski

—
Momino selo

—
Glavatar

ADIS reference number of the outbreak
Area comprising:
Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

Plovdiv region

BG-HPAI(P)-2025-00008BG-HPAI(P)-2025-00009BG-HPAI(P)-2025-000010
The following villages in Rakovski municipality:—Shishmantsi—Boltarino—StrayamaThe following villages in Maritsa municipality:—Manolsko Konare—Yasno pole—Dink—Kalekovets—KrislovoThe following villages in Brezovo municipality:—Padarsko—Borets—Otets Kirilovo—Drangovo—StreltsiThe following villages in Kaloyanovo municipality:—Razhevo—Razhevo Konare—Dalgo pole
—
Shishmantsi
—
Boltarino
—
Strayama
—
Manolsko Konare
—
Yasno pole
—
Dink
—
Kalekovets
—
Krislovo
—
Padarsko
—
Borets
—
Otets Kirilovo
—
Drangovo
—
Streltsi
—
Razhevo
—
Razhevo Konare
—
Dalgo pole
30.9.2025

—
Shishmantsi

—
Boltarino

—
Strayama

—
Manolsko Konare

—
Yasno pole

—
Dink

—
Kalekovets

—
Krislovo

—
Padarsko

—
Borets

—
Otets Kirilovo

—
Drangovo

—
Streltsi

—
Razhevo

—
Razhevo Konare

—
Dalgo pole

The following villages in Rakovski municipality:- Rakovski- Momino seloThe following villages in Kaloyanovo municipality:- Glavatar
22.9.2025 – 30.9.2025

—
Shishmantsi

—
Boltarino

—
Strayama

—
Manolsko Konare

—
Yasno pole

—
Dink

—
Kalekovets

—
Krislovo

—
Padarsko

—
Borets

—
Otets Kirilovo

—
Drangovo

—
Streltsi

—
Razhevo

—
Razhevo Konare

—
Dalgo pole

ADIS reference number of the outbreak
Area comprising:
Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

ES-HPAI(P)-2025-00001
Those parts in the province of Badajoz of the comarca of Azuaga beyond the area described in the protection zone and contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -5,858931247 , lat 38,260806792
28.8.2025

Those parts in the province of Badajoz of the comarca of Azuaga contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -5,858931247 , lat 38,260806792
20.8.2025 – 28.8.2025

ES-HPAI(P)-2025-00002
Those parts in the province of Toledo of the comarcas of Oropesa, Talavera de la Reina and Belvís de la Jara, and in the province of Cáceres of the comarca of Navalmoral de la Mata beyond the area described in the protection zone and contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -5,1395444 , lat 39,8054028
1.9.2025

Those parts in the province of Toledo of the comarcas of Oropesa end Belvis de la Jara contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -5,1395444 , lat 39,8054028
24.8.2025 – 1.9.2025

ES-HPAI(NON-P)-2025-00009
Those parts in the province of Vizcaya contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -2,9450083 , lat 43,4246139
5.9.2025

Those parts in the province of Vizcaya contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -2,9450083 , lat 43,4246139
28.8.2025 – 5.9.2025

ADIS reference number of the outbreak
Area comprising:
Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

PT-HPAI(NON-P)-2025-00014
The parts from the county of Alcácer do Sal from the district of Setúbal, the county of Viana do Alentejo and the county of Montemor-o-Novo both from the district of Évora, that are contained within the circle of 10 kilometers radius, centered on GPS coordinates 38.403607N, -8.316925W
5.9.2025

The parts from the county of Alcácer do Sal from the district of Setúbal and the county of Viana do Alentejo from the district of Évora, that are contained within circle of 3 kilometers radius, centered on GPS coordinates 38.403607N, -8.316925W
28.8.2025 – 5.9.2025

Area comprising:
Date until measures are to remain applicable in accordance with Article 4

*
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023,OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, for the purposes of this Annex, references to Member State include the United Kingdom in respect of Northern Ireland.

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases and amending and repealing certain acts in the area of animal health (‘Animal Health Law’) (1), and in particular Article 259(1), point (c), thereof,

Whereas:

(1) Highly pathogenic avian influenza (HPAI) is an infectious viral disease in birds and can have a severe impact on the profitability of poultry farming causing disturbance to trade within the Union and exports to third countries. HPAI viruses can infect migratory birds, which can then spread these viruses over long distances during their autumn and spring migrations. Therefore, the presence of HPAI viruses in wild birds poses a continuous threat for the direct and indirect introduction of these viruses into holdings where poultry or captive birds are kept. In the event of an outbreak of HPAI, there is a risk that the disease agent may spread to other holdings where poultry or captive birds are kept.

(2) Regulation (EU) 2016/429 establishes the legislative framework for the prevention and control of diseases that are transmissible to animals or humans. HPAI falls within the definition of a listed disease in that Regulation, and it is subject to the disease prevention and control rules laid down therein. In addition, Commission Delegated Regulation (EU) 2020/687 (2) supplements Regulation (EU) 2016/429 as regards the rules for the prevention and control of certain listed diseases, including disease control measures for HPAI.

(3) On 24 October 2023, the Commission adopted Commission Implementing Decision (EU) 2023/2447 (3) on the basis of Regulation (EU) 2016/429, and it lays down emergency measures at Union level in relation to outbreaks of HPAI.

(4) In particular, Implementing Decision (EU) 2023/2447 provides that the protection, surveillance and further restricted zones, to be established by the concerned Member States following outbreaks of HPAI, in accordance with Delegated Regulation (EU) 2020/687, must comprise at least the areas listed as protection, surveillance and further restricted zones in the Annex to that Implementing Decision. It also provides that the measures to be applied in those zones, in accordance with that Delegated Regulation, must be maintained until at least the dates set out in that Annex.

(5) The Annex to Implementing Decision (EU) 2023/2447 was recently amended by Commission Implementing Decision (EU) 2025/1750 (4) following new outbreaks of HPAI in Spain and Portugal in establishments where captive birds were kept, which needed to be reflected in that Annex.

(6) Since the date of adoption of Implementing Decision (EU) 2025/1750, Bulgaria notified the Commission of three outbreaks of HPAI in establishments where poultry were kept, located in the Plovdiv region.

(7) Following those outbreaks, Bulgaria has taken the disease control measures required in accordance with Delegated Regulation (EU) 2020/687, including the establishment of protection and surveillance zones around the outbreaks.

(8) The Commission has examined the disease control measures taken by Bulgaria and it is satisfied that the boundaries of the protection and surveillances zones established by that Member State are at a sufficient distance from the establishment where the outbreaks of HPAI have been confirmed.

(9) In the Annex to Implementing Decision (EU) 2023/2447, there are currently no areas listed as protection and surveillance zones for Bulgaria.

(10) In order to prevent any unnecessary disturbance to trade within the Union and to avoid unjustified barriers to trade being imposed by third countries, it is necessary to rapidly lay down at Union level, in collaboration with Bulgaria, the protection and surveillance zones established by that Member State, in accordance with Delegated Regulation (EU) 2020/687.

(11) Therefore, protection and surveillance zones for Bulgaria should be listed in the Annex to Implementing Decision (EU) 2023/2447.

(12) Accordingly, the Annex to Implementing Decision (EU) 2023/2447 should be amended to update regionalisation at Union level in order to take account of the protection and surveillance zones established by Bulgaria, in accordance with Delegated Regulation (EU) 2020/687, as well as to set out the duration of the measures applicable therein.

(13) Implementing Decision (EU) 2023/2447 should therefore be amended accordingly.

(14) Given the urgency of the epidemiological situation in the Union as regards the spread of HPAI, it is important that the amendments to be made to Implementing Decision (EU) 2023/2447 by this Decision take effect as soon as possible.

(15) The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

HAS ADOPTED THIS DECISION:
The Annex to Implementing Decision (EU) 2023/2447 is replaced by the text set out in the Annex to this Decision.
This Decision is addressed to the Member States.
Part A
Protection zones in the concerned Member States* as referred to in Article 1, point (a), and Article 2:
Member State: Bulgaria

ADIS reference number of the outbreak

Area comprising:

Date until applicable in accordance with Article 39 of Delegated Regulation (EU) 2020/687

Plovdiv region

BG-HPAI(P)-2025-00008

BG-HPAI(P)-2025-00009

BG-HPAI(P)-2025-000010

The following villages in Rakovski municipality:

—

Rakovski

—

Momino selo

The following villages in Kaloyanovo municipality:

—

Glavatar

21.9.2025

Part B
Surveillance zones in the concerned Member States* as referred to in Article 1, point (a), and Article 3:
Member State: Bulgaria

ADIS reference number of the outbreak

Area comprising:

Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

Plovdiv region

BG-HPAI(P)-2025-00008

BG-HPAI(P)-2025-00009

BG-HPAI(P)-2025-000010

The following villages in Rakovski municipality:

—

Shishmantsi

—

Boltarino

—

Strayama

The following villages in Maritsa municipality:

—

Manolsko Konare

—

Yasno pole

—

Dink

—

Kalekovets

—

Krislovo

The following villages in Brezovo municipality:

—

Padarsko

—

Borets

—

Otets Kirilovo

—

Drangovo

—

Streltsi

The following villages in Kaloyanovo municipality:

—

Razhevo

—

Razhevo Konare

—

Dalgo pole

30.9.2025

The following villages in Rakovski municipality:

– Rakovski

– Momino selo

The following villages in Kaloyanovo municipality:

– Glavatar

22.9.2025 – 30.9.2025

Member State: Spain

ADIS reference number of the outbreak

Area comprising:

Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

ES-HPAI(P)-2025-00001

Those parts in the province of Badajoz of the comarca of Azuaga beyond the area described in the protection zone and contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -5,858931247 , lat 38,260806792

28.8.2025

Those parts in the province of Badajoz of the comarca of Azuaga contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -5,858931247 , lat 38,260806792

20.8.2025 – 28.8.2025

ES-HPAI(P)-2025-00002

Those parts in the province of Toledo of the comarcas of Oropesa, Talavera de la Reina and Belvís de la Jara, and in the province of Cáceres of the comarca of Navalmoral de la Mata beyond the area described in the protection zone and contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -5,1395444 , lat 39,8054028

1.9.2025

Those parts in the province of Toledo of the comarcas of Oropesa end Belvis de la Jara contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -5,1395444 , lat 39,8054028

24.8.2025 – 1.9.2025

ES-HPAI(NON-P)-2025-00009

Those parts in the province of Vizcaya contained within a circle of a radius of 10 kilometres, centered on UTM 30, ETRS89 coordinates long -2,9450083 , lat 43,4246139

5.9.2025

Those parts in the province of Vizcaya contained within a circle of a radius of 3 kilometres, centered on UTM 30, ETRS89 coordinates long -2,9450083 , lat 43,4246139

28.8.2025 – 5.9.2025

Member State: Portugal

ADIS reference number of the outbreak

Area comprising:

Date until applicable in accordance with Article 55 of Delegated Regulation (EU) 2020/687

PT-HPAI(NON-P)-2025-00014

The parts from the county of Alcácer do Sal from the district of Setúbal, the county of Viana do Alentejo and the county of Montemor-o-Novo both from the district of Évora, that are contained within the circle of 10 kilometers radius, centered on GPS coordinates 38.403607N, -8.316925W

5.9.2025

The parts from the county of Alcácer do Sal from the district of Setúbal and the county of Viana do Alentejo from the district of Évora, that are contained within circle of 3 kilometers radius, centered on GPS coordinates 38.403607N, -8.316925W

28.8.2025 – 5.9.2025

Part C
Further restricted zones in the concerned Member States* as referred to in Article 1, point (b), and Article 4:
Member State: None

Area comprising:

Date until measures are to remain applicable in accordance with Article 4

*

In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, for the purposes of this Annex, references to Member State include the United Kingdom in respect of Northern Ireland.

Political and Security Committee Decision (CFSP) 2025/1773 of 27 August 2025 on the appointment of the Head of Mission of the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA) (EUAM RCA/1/2025)

                                January 13, 2026                            

Official Journalof the European Union
ENL series

2025/1773
2.9.2025

(1)
Pursuant to Article 8(1) of Decision (CFSP) 2019/2110, the Political and Security Committee (PSC) is authorised, in accordance with Article 38, third paragraph, of the Treaty, to take the relevant decisions for the purpose of exercising political control and strategic direction of the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA), including the decision to appoint a Head of Mission, upon a proposal of the High Representative of the Union for Foreign Affairs and Security Policy (the ‘High Representative’).

(2)
On 25 August 2022, the PSC adopted Decision (CFSP) 2022/1436(2), appointing Mr José Manuel MARQUES DIAS as Head of Mission of EUAM RCA from 1 September 2022 to 31 August 2023.

(3)
On 21 October 2024, the Council adopted Decision (CFSP) 2024/2723(3)amending Decision (CFSP) 2019/2110 and extending the mandate of EUAM RCA to 7 August 2026.

(4)
On 22 October 2024, the PSC adopted Decision (CFSP) 2024/2796(4)extending the mandate of Mr José Manuel MARQUES DIAS as Head of Mission of EUAM RCA from 1 November 2024 to 9 August 2025.

(5)
On 25 July 2025, the High Representative proposed the appointment of Ms Gail VAN HOEVER as Head of Mission of EUAM RCA from 15 September 2025 to 7 August 2026.

(6)
A decision on the appointment of Ms Gail VAN HOEVER as Head of Mission EUAM RCA from 15 September 2025 to 7 August 2026 should therefore be taken,

THE POLITICAL AND SECURITY COMMITTEE,

Having regard to the Treaty on European Union, and in particular Article 38, third paragraph, thereof,

Having regard to Council Decision (CFSP) 2019/2110 of 9 December 2019 on the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA) (1), and in particular Article 8(1) thereof,

Whereas:

(1) Pursuant to Article 8(1) of Decision (CFSP) 2019/2110, the Political and Security Committee (PSC) is authorised, in accordance with Article 38, third paragraph, of the Treaty, to take the relevant decisions for the purpose of exercising political control and strategic direction of the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA), including the decision to appoint a Head of Mission, upon a proposal of the High Representative of the Union for Foreign Affairs and Security Policy (the ‘High Representative’).

(2) On 25 August 2022, the PSC adopted Decision (CFSP) 2022/1436 (2), appointing Mr José Manuel MARQUES DIAS as Head of Mission of EUAM RCA from 1 September 2022 to 31 August 2023.

(3) On 21 October 2024, the Council adopted Decision (CFSP) 2024/2723 (3) amending Decision (CFSP) 2019/2110 and extending the mandate of EUAM RCA to 7 August 2026.

(4) On 22 October 2024, the PSC adopted Decision (CFSP) 2024/2796 (4) extending the mandate of Mr José Manuel MARQUES DIAS as Head of Mission of EUAM RCA from 1 November 2024 to 9 August 2025.

(5) On 25 July 2025, the High Representative proposed the appointment of Ms Gail VAN HOEVER as Head of Mission of EUAM RCA from 15 September 2025 to 7 August 2026.

(6) A decision on the appointment of Ms Gail VAN HOEVER as Head of Mission EUAM RCA from 15 September 2025 to 7 August 2026 should therefore be taken,

HAS ADOPTED THIS DECISION:
Ms Gail VAN HOEVER is appointed as Head of Mission of the European Union CSDP Advisory Mission in the Central African Republic (EUAM RCA) from 15 September 2025 to 7 August 2026.
This Decision shall enter into force on the date of its adoption.

	Names (Transliteration into Latin script)	Names	Identifying information	Reasons for listing	Date of listing
‘134.	Vadim Viktorovich BULGAKOVa.k.a.Vadym Viktorovych BULHAKOV	Вадим Викторович БУЛГАКОВ(Russian spelling)	Position: Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”DOB: 30.1.1969POB: Simferopol, UkraineNationality: Ukrainian, RussianTax ID Ukraine (ДРФО): 2523214611Tax ID Russia (ИНН): 910218275068Gender: maleAddress: Simferopol, Autonomous Republic of Crimea, UkraineAssociated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Aleksei Nikolaevich Pikin, Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”	Since November 2014, Vadim Bulgakov is the Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”. He holds sole authority over the Directorate’s activities and, as such, bears personal responsibility for, among other things, the proper provision of medical services to detainees and prisoners in Crimea. In this capacity, he is accountable for the widespread and systematic denial of adequate medical care and treatment to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.Since his appointment as Head of the Directorate in 2014, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.Therefore, Vadim Bulgakov is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.	5.9.2025
135.	Aleksei Nikolaevich PIKINa.k.a.Alexey Nikolaevich PIKIN	Алексей Николаевич ПИКИН(Russian spelling)	Position: Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”DOB: 9.8.1975Nationality: RussianGender: maleAddress: Voronezh, Voronezh Region, RussiaAssociated individuals: Arkady Alexandrovich Gostev, Director of the Russian Federal Penitentiary Service Vadim Viktorovich Bulgakov, Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol”	Aleksei Pikin is the Deputy Head of the Directorate of the Russian Federal Penal Enforcement Service for the “Republic of Crimea and the City of Sevastopol” since May 2016. Within that structure, he holds responsibility for the management and coordination of the regional penal system in Crimea and Sevastopol, including staff conduct, inmate welfare, and the prevention of law violations within detention facilities. Given this mandate, he bears responsibility for any human rights violations committed against individuals sentenced to imprisonment in Crimea, including abuses by staff, unlawful disciplinary measures, or failure to prevent torture, mistreatment, or denial of basic rights within the penal system. He is accountable for widespread and systematic denial of adequate medical care and treatment provision to detainees and prisoners, in particular political prisoners. This amounts to cruel, inhuman or degrading treatment.Since his appointment as Deputy Head in 2016, widespread and systematic human rights violations in Crimean detention centres have been documented by the United Nations and the European Court of Human Rights. In particular, the administrative practice of ill-treatment and denial of medical care to political prisoners, which constitutes an act of cruel, inhuman, or degrading treatment or punishment, has repeatedly occurred under his authority at the Simferopol detention centre in Crimea since his appointment. He is, in particular, responsible for the ill-treatment of human rights defenders Iryna Danylovych and Amet Suleymanov, who were denied proper medical care for several months during their imprisonment in the Simferopol detention centre.Therefore, Aleksei Pikin is responsible for serious human rights violations or abuses, namely cruel, inhuman or degrading treatment or punishment, in particular in relation to political prisoners held in detention centres in Crimea.	5.9.2025’

(1)	DAF TRUCKS N.V.P.O. Box 900655600 PT EindhovenThe Netherlands	DAF TRUCKS N.V.	P.O. Box 90065	5600 PT Eindhoven	The Netherlands
DAF TRUCKS N.V.
P.O. Box 90065
5600 PT Eindhoven
The Netherlands

(2)	DAIMLER TRUCK AGFasanenweg 1070771 Leinfelden-EchterdingenGermany	DAIMLER TRUCK AG	Fasanenweg 10	70771 Leinfelden-Echterdingen	Germany
DAIMLER TRUCK AG
Fasanenweg 10
70771 Leinfelden-Echterdingen
Germany

(3)	FORD OTOMOTIV SANAYI A.Ş.Akpınar Mahallesi Hasan Basri Caddesi No: 234885 Sancaktepe/İstanbulTürkiye	FORD OTOMOTIV SANAYI A.Ş.	Akpınar Mahallesi Hasan Basri Caddesi No: 2	34885 Sancaktepe/İstanbul	Türkiye
FORD OTOMOTIV SANAYI A.Ş.
Akpınar Mahallesi Hasan Basri Caddesi No: 2
34885 Sancaktepe/İstanbul
Türkiye

(4)	HYUNDAI HYDROGEN MOBILITY AGHagenholzstrasse 608004 ZürichSwitzerland	HYUNDAI HYDROGEN MOBILITY AG	Hagenholzstrasse 60	8004 Zürich	Switzerland
HYUNDAI HYDROGEN MOBILITY AG
Hagenholzstrasse 60
8004 Zürich
Switzerland

(5)	IVECO MAGIRUS AGNicolaus-Otto-Straße 2789079 UlmGermany	IVECO MAGIRUS AG	Nicolaus-Otto-Straße 27	89079 Ulm	Germany
IVECO MAGIRUS AG
Nicolaus-Otto-Straße 27
89079 Ulm
Germany

(6)	IVECO S.P.A.Via Puglia 3510156 TorinoItaly	IVECO S.P.A.	Via Puglia 35	10156 Torino	Italy
IVECO S.P.A.
Via Puglia 35
10156 Torino
Italy

(7)	MAN TRUCK & BUS SEDachauer Straße 66780995 MünchenGermany	MAN TRUCK & BUS SE	Dachauer Straße 667	80995 München	Germany
MAN TRUCK & BUS SE
Dachauer Straße 667
80995 München
Germany

(8)	OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 534788 Çekmeköy/İstanbulTürkiye	OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.	Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5	34788 Çekmeköy/İstanbul	Türkiye
OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.
Taşdelen Mahallesi Sırrı Çelik Bulvarı No: 5
34788 Çekmeköy/İstanbul
Türkiye

(9)	RENAULT TRUCK SAS99 Route de Lyon69800 Saint-PriestFrance	RENAULT TRUCK SAS	99 Route de Lyon	69800 Saint-Priest	France
RENAULT TRUCK SAS
99 Route de Lyon
69800 Saint-Priest
France

(10)	SCANIA CV ABVagnmakarvägen 1151 87 SödertäljeSweden	SCANIA CV AB	Vagnmakarvägen 1	151 87 Södertälje	Sweden
SCANIA CV AB
Vagnmakarvägen 1
151 87 Södertälje
Sweden

(11)	VOLVO TRUCK CORPORATIONHerkulesgatan 75405 08 GöteborgSweden	VOLVO TRUCK CORPORATION	Herkulesgatan 75	405 08 Göteborg	Sweden
VOLVO TRUCK CORPORATION
Herkulesgatan 75
405 08 Göteborg
Sweden

Manufacturer	Average specific CO2emissions, as referred to in Article 4 of Regulation (EU) 2019/1242, in g/tkm	Zero- and low emission factor, as referred to in Article 5(1) of Regulation (EU) 2019/1242	CO2emissions reduction trajectory, as referred to in Article 7(2) of Regulation (EU) 2019/1242, in g/tkm	Emission credits, as referred to in Article 7(1) of Regulation (EU) 2019/1242, in g/tkm
DAF TRUCKS N.V.	47,72	0,999	49,54	64 053
DAIMLER TRUCK AG	47,75	0,990	47,45	–
FORD OTOMOTIV SANAYI A.Ş.	52,55	1,000	49,12	–
HYUNDAI HYDROGEN MOBILITY AG	0,00	0,970	50,60	1 518
IVECO MAGIRUS AG	50,08	1,000	46,35	–
IVECO S.P.A.	47,91	0,983	45,11	–
MAN TRUCK & BUS SE	46,68	0,999	47,29	20 456
OTOKAR OTOMOTIV VE SAVUNMA SANAYI A.Ş.	36,21	1,000	28,52	–
RENAULT TRUCK SAS	43,45	0,970	45,70	45 111
SCANIA CV AB	44,13	0,996	48,38	168 905
VOLVO TRUCK CORPORATION	44,47	0,970	48,64	165 470

ADIS reference number of the outbreak	Area comprising:	Date until applicable in accordance with Article 39 of Delegated Regulation (EU) 2020/687
Plovdiv region
BG-HPAI(P)-2025-00008BG-HPAI(P)-2025-00009BG-HPAI(P)-2025-000010	The following villages in Rakovski municipality:—Rakovski—Momino seloThe following villages in Kaloyanovo municipality:—Glavatar	—	Rakovski	—	Momino selo	—	Glavatar	21.9.2025
—	Rakovski
—	Momino selo
—	Glavatar

Area comprising:	Date until measures are to remain applicable in accordance with Article 4